Laurie Havanec - CVS Health Ex Officer
| CVS Stock | MXN 1,214 21.10 1.71% |
Insider
Laurie Havanec is Ex Officer of CVS Health
| Age | 62 |
| Phone | 401-765-1500 |
| Web | https://www.cvshealth.com |
Laurie Havanec Latest Insider Activity
Tracking and analyzing the buying and selling activities of Laurie Havanec against CVS Health stock is an integral part of due diligence when investing in CVS Health. Laurie Havanec insider activity provides valuable insight into whether CVS Health is net buyers or sellers over its current business cycle. Note, CVS Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell CVS Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Laurie Havanec over six months ago Disposition of 6698 shares by Laurie Havanec of CVS Health at 76.43 subject to Rule 16b-3 |
CVS Health Management Efficiency
The company has return on total asset (ROA) of 0.0418 % which means that it generated a profit of $0.0418 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0568 %, meaning that it generated $0.0568 on every $100 dollars invested by stockholders. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| John Laughter | Delta Air Lines | 52 | |
| Rohit Gupta | Genworth Financial | 48 | |
| Christiana Riley | Deutsche Bank Aktiengesellschaf | 45 | |
| Matthew Friedrich | UnitedHealth Group Incorporated | 53 | |
| CFA IV | Genworth Financial | 57 | |
| D Wilson | UnitedHealth Group Incorporated | 60 | |
| Alain Bellemare | Delta Air Lines | 62 | |
| Brian Haendiges | Genworth Financial | 62 | |
| Robert Rivkin | United Airlines Holdings | 62 | |
| Kazutoshi Kuwahara | Genworth Financial | N/A | |
| Garrett Chase | Delta Air Lines | 51 | |
| Michael CFA | United Airlines Holdings | N/A | |
| James Barry | UnitedHealth Group Incorporated | 77 | |
| Philip Smith | The Bank of | N/A | |
| F McNabb | UnitedHealth Group Incorporated | 61 | |
| Vinod Bagal | DXC Technology | 57 | |
| John II | Genworth Financial | N/A | |
| Rebecca Short | Deutsche Bank Aktiengesellschaf | 49 | |
| Don Mitacek | Delta Air Lines | 60 | |
| H Diao | DXC Technology | 66 | |
| Josh Earnest | United Airlines Holdings | N/A | |
Management Performance
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 |
CVS Health Leadership Team
Elected by the shareholders, the CVS Health's board of directors comprises two types of representatives: CVS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS Health's management team and ensure that shareholders' interests are well served. CVS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Moriarty, Chief Health Care Strategy Officer, Executive VP and General Counsel | ||
| Tilak Mandadi, Digital Data | ||
| Shawn Guertin, Ex CFO | ||
| Larry McGrath, Sr Relations | ||
| James Clark, Senior Vice President Chief Accounting Officer, Controller | ||
| Alan MD, Ex Services | ||
| David Falkowski, Ex Officer | ||
| Norman Greve, Chief Officer | ||
| Laurie Havanec, Ex Officer | ||
| Karen Lynch, CEO Pres |
CVS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 3.58 T | |||
| Shares Outstanding | 1.28 B | |||
| Shares Owned By Insiders | 0.40 % | |||
| Shares Owned By Institutions | 82.77 % | |||
| Price To Earning | 398.88 X | |||
| Price To Book | 1.83 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.